Investigating how platelets influence cancer progression

Platelet Serine/Threonine Phosphatases in Cancer Pathophysiology

NIH-funded research Baylor College of Medicine · NIH-10992103

This study is looking at how platelets in the blood help lung cancer cells survive and spread, with the goal of finding new ways to treat the disease and improve outcomes for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-10992103 on NIH RePORTER

What this research studies

This research explores the role of platelets in the progression of lung cancer, particularly how they interact with tumor cells in the bloodstream. It aims to understand the mechanisms by which platelets support the survival of circulating tumor cells and contribute to metastasis. By examining changes in platelet proteins in cancer patients, the study seeks to identify potential new targets for treatment that could improve patient outcomes. The research employs advanced proteomic techniques to analyze platelet samples from lung cancer patients.

Who could benefit from this research

Good fit: Ideal candidates for this research are lung cancer patients, particularly those with high platelet counts.

Not a fit: Patients with early-stage lung cancer or those not undergoing treatment may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies that enhance the effectiveness of cancer treatments and improve survival rates for lung cancer patients.

How similar studies have performed: Previous research has shown promising results in understanding the role of platelets in cancer, suggesting that this approach could yield valuable insights.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions anti-cancer immunotherapyanti-cancer researchanticancer immunotherapy
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.